Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will be participating in a fireside chat with Farzin Haque, Biotechnology Equity Research Analyst, Jefferies, at the Jefferies Healthcare Conference in London, on Monday 17 November, 2025. Aguiar-Lucander will also present Hansa Biopharma at DNB Carnegie’s 16 th Annual Nordic Healthcare Conference in Oslo, Tuesday 25 November, 2025.
Thursday, November 13, 2025 - Tuesday, November 25, 2025
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will be participating in a fireside chat with Farzin Haque, Biotechnology Equity Research Analyst, Jefferies, at the Jefferies Healthcare Conference in London, on Monday 17 November, 2025. Aguiar-Lucander will also present Hansa Biopharma at DNB Carnegie’s 16 th Annual Nordic Healthcare Conference in Oslo, Tuesday 25 November, 2025.
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →Hansa Biopharma presenting at Jefferies Global Healthcare Conference and DNB Carnegie’s 16th Annual Nordic Healthcare Conference takes place on Thursday, November 13, 2025 to Tuesday, November 25, 2025.
Hansa Biopharma presenting at Jefferies Global Healthcare Conference and DNB Carnegie’s 16th Annual Nordic Healthcare Conference is held in London at Waldorf Hilton.
Pricing information is available on the event website.
Hansa Biopharma presenting at Jefferies Global Healthcare Conference and DNB Carnegie’s 16th Annual Nordic Healthcare Conference is designed for healthcare professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox